Revolutionizing the manufacturing of medical, diagnostic, disposable, and microfluidic devices.
Established in 2010, Ginolis is headquartered in Oulu, Finland. The company is privileged to work in co-operation with many of the world’s leading diagnostic companies.
Improved supply chain productivity & flexibility
Through long term partnerships with Ginolis, our customers can improve their supply chain productivity and flexibility by utilizing modular desktop automation in the manufacturing of medical, diagnostic disposable, and microfluidic devices.

Our values
Justice & Equality
We respect each other and treat everybody fairly.
Technology & Innovation
We believe in technology, innovation, teamwork and good business management.
Speed & Flexibility
We work fast and flexibly without compromising quality.
Truth & Transparency
We keep our promises and always tell the truth.
Want to join us? We are looking for talent!
No result for in
Our Story
Established in Oulu, Finland
Global Innovation Network (GIN) is founded in Oulu, Finland.
2010
2011
Headquarters opened in Oulunsalo
Delilah is launched
Modular desktop automation platform Delilah is launched.
2012
2013
First major delivery
First major delivery: Automated reagent dispensing line to Fiomi Diagnostics (now Trinity Biotech).
PMB nanolitre dispensing pump is launched.
Acquisition and name change
GIN acquires Sigolis (est. 2007) Sweden for microfluidic technology IPR.
Global Innovation Network (GIN) changes name to Ginolis
2014
2015
Expand to USA
Ginolis expands to North America and opens an office in San Diego, USA.
Major delivery: Fully automated production line for Tandem Diabetes Care insulin pumps.
Product launch
Launch and first delivery of revolutionizing Lateral Flow Device Assembly (LFDA) system.
2016
2017
Ginolis expands to Asia
Ginolis expands to China and opens an office in Suzhou.
Product launch
Launch of Pixie, a standard system for automated optical quality inspection.
2018
2019
Distribution agreement and product launch
Ginolis and MDS (Japan) sign a distributor agreement.
Ginolis launches a new model of the high precision PMBi dispensing pump.
Ginolis expands to the US east coast.
Product launch
Launch of LFDA-1, a semi-automated assembly solution for lateral flow devices.
2020
2021
Ginolis becomes part of CELLINK Group
Since March 2021 we are a proud and happy part of the CELLINK family and we are on the road to success constantly looking for new team members.
In August 2021, CELLINK became BICO Group.
About us

GINOLIS is a part of BICO and the Bio-convergence revolution. Our products and services combine the power of biology, engineering and computer science to create the future of health.
Read more at BICO.com
Read more at BICO.com
© Ginolis Oy | Privacy policy